Advertisement
Advertisement
GALT
Galectin Therapeutics Inc.
3.14
USDSponsored
+0.16
+5.19%
Nov 06, 15:59 UTC -5
Closed
After-Market
3.04
-0.10
-3.03%
Galectin Therapeutics Inc. (GALT)
Galectin Therapeutics Inc. Financial Snapshot
| Market Cap | 307.09M |
| Beta | 0.53 |
| Earnings Per Share (EPS) | -0.43 |
| Price-to-Book (P/B) Ratio | -- |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | -100.62% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -- |
| Current Ratio | 0.10% |
| Free Cash Flow | -6.30M |
